US Patent Issued to Novartis on April 7 for "Methods of treating psoriasis with secukinumab" (Swiss, German Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,332, issued on April 7, was assigned to Novartis AG (Basel, Switzerland).

"Methods of treating psoriasis with secukinumab" was invented by Achim Guettner (Binzen, Germany), Matthias Machacek (Allschwil, Switzerland), Charis Papavassilis (Loerrach, Germany) and Oliver Sander (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to novel regimens for treating psoriasis, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., an IL-17 binding molecule, e.g., an IL-17 antibody, such as the secukinumab antibody, or an IL-17 receptor binding molecule, e.g., an IL-17 receptor antibody."

The patent ...